Albuterol HFA MDI in Pediatric Participants With Asthma

Study Title
Albuterol HFA MDI in Pediatric Participants With Asthma
Teva Identifier
IXR-302-25-105
ClinicalTrials.gov Identifier
NCT00577655
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol | Drug: Placebo | Drug: Proventilֲ® HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
4 Years to 11 Years
Trial Duration
08/01/2007 - 07/01/2008
Phase
Phase 3

Study Type

Interventional